S&CO Inc. Acquires New Holdings in Privia Health Group, Inc. $PRVA

S&CO Inc. bought a new position in Privia Health Group, Inc. (NASDAQ:PRVA) during the 2nd quarter, Holdings Channel reports. The institutional investor bought 42,000 shares of the company’s stock, valued at approximately $1,080,000.

Other large investors have also added to or reduced their stakes in the company. Bayban purchased a new stake in Privia Health Group during the 4th quarter valued at $26,000. Hantz Financial Services Inc. grew its holdings in shares of Privia Health Group by 456.2% in the fourth quarter. Hantz Financial Services Inc. now owns 1,129 shares of the company’s stock worth $27,000 after acquiring an additional 926 shares during the period. Global Retirement Partners LLC grew its holdings in shares of Privia Health Group by 579.8% in the fourth quarter. Global Retirement Partners LLC now owns 1,584 shares of the company’s stock worth $38,000 after acquiring an additional 1,351 shares during the period. Harbor Investment Advisory LLC purchased a new stake in Privia Health Group during the second quarter valued at $69,000. Finally, Canada Pension Plan Investment Board increased its position in Privia Health Group by 48.0% during the second quarter. Canada Pension Plan Investment Board now owns 3,700 shares of the company’s stock valued at $85,000 after acquiring an additional 1,200 shares during the last quarter. Institutional investors own 94.48% of the company’s stock.

Insider Activity at Privia Health Group

In other news, Director Matthew Shawn Morris sold 88,110 shares of the firm’s stock in a transaction on Friday, June 26th. The shares were sold at an average price of $25.33, for a total transaction of $2,231,826.30. Following the sale, the director directly owned 76,651 shares in the company, valued at $1,941,569.83. This trade represents a 53.48% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO David Mountcastle sold 24,734 shares of the firm’s stock in a transaction on Thursday, July 2nd. The shares were sold at an average price of $27.50, for a total transaction of $680,185.00. Following the sale, the chief financial officer owned 186,728 shares in the company, valued at $5,135,020. The trade was a 11.70% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 327,886 shares of company stock worth $8,628,256 in the last ninety days. Insiders own 5.70% of the company’s stock.

Privia Health Group Trading Up 1.1%

Privia Health Group stock opened at $22.00 on Friday. Privia Health Group, Inc. has a 12-month low of $19.53 and a 12-month high of $28.82. The firm has a market capitalization of $2.81 billion, a price-to-earnings ratio of 104.77, a P/E/G ratio of 1.77 and a beta of 0.85. The firm has a 50 day moving average of $24.71 and a 200 day moving average of $23.29.

Wall Street Analyst Weigh In

PRVA has been the topic of a number of recent research reports. Zacks Research raised Privia Health Group from a “strong sell” rating to a “hold” rating in a report on Wednesday, August 5th. Canaccord Genuity Group set a $32.00 price target on shares of Privia Health Group in a research report on Friday, August 7th. Weiss Ratings raised shares of Privia Health Group from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, July 2nd. Barclays dropped their price objective on shares of Privia Health Group from $25.00 to $24.00 and set an “equal weight” rating on the stock in a report on Tuesday, May 26th. Finally, Citigroup restated a “buy” rating on shares of Privia Health Group in a research report on Thursday, July 23rd. Eleven investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $31.00.

Privia Health Group Company Profile

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.